MARKET

AGN

AGN

Allergan
NYSE

Real-time Quotes | Nasdaq Last Sale

188.19
-2.41
-1.26%
After Hours: 188.58 +0.39 +0.21% 19:59 01/24 EST
OPEN
190.00
PREV CLOSE
190.60
HIGH
190.39
LOW
187.82
VOLUME
3.45M
TURNOVER
--
52 WEEK HIGH
194.61
52 WEEK LOW
114.27
MARKET CAP
61.78B
P/E (TTM)
-6.7480
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AGN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 19 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AGN News

  • Should You Buy Allergan Before the AbbVie Acquisition Closes?
  • MotleyFool.com.14h ago
  • Is Mylan Stock a Buy?
  • MotleyFool.com.1d ago
  • Allergan declares $0.74 dividend
  • seekingalpha.2d ago
  • Better Buy: AbbVie vs. Johnson & Johnson
  • MotleyFool.com.2d ago

More

Industry

Pharmaceuticals
-1.84%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About AGN

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States.
More

Webull offers Allergan plc (AGN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.